We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > concizumab

News List

Novo Nordisk resumes late-stage haemophilia trials pharmatimes
August 17, 2020
Novo Nordisk is set to resume the phase 3 clinical trials of concizumab in haemophilia A and B, with or without inhibitors, following a previous safety scare.
Concizumab haemophilia trials paused over safety concerns europeanpharmaceuticalreview
March 19, 2020
The occurrence of non-fatal thrombotic events in Phase III study participants has called into question the safety of concizumab.
Novo cancels haemophilia drug Phase III trial pharmatimes
March 18, 2020
Novo Nordisk has paused the Phase III explorer7 and explorer8 trials for haemophilia drug concizumab, due to non-fatal thrombotic events, the company says.